These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 240483)

  • 1. Alterations in neostriatum tyrosine hydroxylase activity and behavior induced by electrical stimulation of the substantia nigra.
    Schlehuber CJ; Segal DS; Spooner CE
    Brain Res; 1975 Jun; 91(2):341-7. PubMed ID: 240483
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopaminergic neurons: effects of electrical stimulation on tyrosine hydroxylase.
    Murrin LC; Morgenroth VH; Roth RH
    Mol Pharmacol; 1976 Nov; 12(6):1070-81. PubMed ID: 12461
    [No Abstract]   [Full Text] [Related]  

  • 3. Opiate-receptors in substantia nigra: role in the regulation of striatal tyrosine hydroxylase activity.
    Gale K; Moroni F; Kumakura K; Guidotti A
    Neuropharmacology; 1979 Apr; 18(4):427-30. PubMed ID: 36574
    [No Abstract]   [Full Text] [Related]  

  • 4. GABA-mediated control of rat neostriatal tyrosine hydroxylase revealed by intranigral muscimol.
    Gale KN; Guidotti A
    Nature; 1976 Oct; 263(5579):691-3. PubMed ID: 10528
    [No Abstract]   [Full Text] [Related]  

  • 5. Tyrosine hydroxylase activity: regional and subcellular distribution in the brain.
    Segal DS; Kuczenski R
    Brain Res; 1974 Mar; 68(2):261-6. PubMed ID: 4151196
    [No Abstract]   [Full Text] [Related]  

  • 6. Alterations in behaviour and catecholamine biosynthesis induced by lithium.
    Segal DS; Callaghan M; Mandell AJ
    Nature; 1975 Mar; 254(5495):58-9. PubMed ID: 234597
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic selegiline administration transiently decreases tyrosine hydroxylase activity and mRNA in the rat nigrostriatal pathway.
    Vrana SL; Azzaro AJ; Vrana KE
    Mol Pharmacol; 1992 May; 41(5):839-44. PubMed ID: 1350320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible changes in the activities and amounts of tyrosine hydroxylase in dopamine neurons of the substantia nigra in response to axonal injury as studied by immunochemical and immunocytochemical methods.
    Reis DJ; Gilad G; Pickel VM; Joh TH
    Brain Res; 1978 Apr; 144(2):325-42. PubMed ID: 25123
    [No Abstract]   [Full Text] [Related]  

  • 9. Homospecific activity (activity per enzyme protein) of tyrosine hydroxylase increases in parkinsonian brain.
    Mogi M; Harada M; Kiuchi K; Kojima K; Kondo T; Narabayashi H; Rausch D; Riederer P; Jellinger K; Nagatsu T
    J Neural Transm; 1988; 72(1):77-82. PubMed ID: 2897999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a role of nigral gamma-aminobutyric acid and substance P in the haloperidol-induced activation of striatal tyrosine hydroxylase.
    Gale K; Costa E; Toffano G; Hong JS; Guidotti A
    J Pharmacol Exp Ther; 1978 Jul; 206(1):29-37. PubMed ID: 26799
    [No Abstract]   [Full Text] [Related]  

  • 11. Reduced tyrosine hydroxylase activity in nigrostriatal system of sinoaortic-denervated rats.
    Alexander N; Hirata Y; Nagatsu T
    Brain Res; 1984 May; 299(2):380-2. PubMed ID: 6145496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic cocaine administration depletes tyrosine hydroxylase immunoreactivity in the rat brain nigral striatal system: quantitative light microscopic studies.
    Trulson ME; Babb S; Joe JC; Raese JD
    Exp Neurol; 1986 Dec; 94(3):744-56. PubMed ID: 2877900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early behavioural effects of intraventricular administration of 6-hydroxydopamine in rat.
    Fibiger HC; Lonsbury B; Cooper HP; Lytle LD
    Nat New Biol; 1972 Apr; 236(68):209-11. PubMed ID: 4401617
    [No Abstract]   [Full Text] [Related]  

  • 14. Dynamic changes in activity and amounts of tyrosine hydroxylase in the dopaminergic nigrostriatal system in response to axonal damage.
    Reis DJ; Gilad G; Joh TH
    Trans Am Neurol Assoc; 1975; 100():229-31. PubMed ID: 5797
    [No Abstract]   [Full Text] [Related]  

  • 15. 6-Hydroxydopamine and striatal acetylcholine levels.
    Grewaal DS; Fibiger HC; McGeer EG
    Brain Res; 1974 Jun; 73(2):372-5. PubMed ID: 4151550
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in levels of dopamine and tyramine in the rat caudate nucleus following alterations in impulse flow in the nigrostriatal pathway.
    Jones RS; Juorio AV; Boulton AA
    J Neurochem; 1983 Feb; 40(2):396-401. PubMed ID: 6130125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The turnover rate of gamma-aminobutyric acid in the substantia nigra following electrical stimulation or lesioning of the strionigral pathways.
    Mao CC; Peralta E; Morini F; Costa E
    Brain Res; 1978 Oct; 155(1):147-52. PubMed ID: 688008
    [No Abstract]   [Full Text] [Related]  

  • 18. Abnormal expression of tyrosine hydroxylase-like immunoreactivity in intraocular transplants of rat caudate nucleus.
    Mahalik TJ; Stromberg I; Finger TE; Olson L
    Neurosci Lett; 1989 Jan; 96(3):253-8. PubMed ID: 2566137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylcholinesterase in the substantia nigra and caudate-putamen of the rat: properties and localization in dopaminergic neurons.
    Lehmann J; Fibiger HC
    J Neurochem; 1978 Mar; 30(3):615-24. PubMed ID: 681936
    [No Abstract]   [Full Text] [Related]  

  • 20. A kinetic scattering approach to the non-linear instabilities of rat brain tyrosine hydroxylase preparations at several levels of tetrahydrobiopterin cofactor demonstrates evolutionary behavior characteristic of global dynamical systems.
    Russo PV; Mandell AJ
    Brain Res; 1984 May; 299(2):313-22. PubMed ID: 6145494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.